Cornelis J A Punt, Linda Mol, Miriam Koopman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Angiogenesis Inhibitors/adverse effectsAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedBevacizumabHumansMeta-Analysis as TopicMortalityNeoplasms/drug therapyPatient Care/standardsRandomized Controlled Trials as Topic
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2011 PMID： 21642679 DOI： 10.1001/jama.2011.758
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272